Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Non-Alcoholic Steatohepatitis: A Clinical Review Article

Non-alcoholic fatty liver disease (NAFLD) has emerged as one of the lethal causes of chronic liver disease globally. NAFLD can ultimately progress to non-alcoholic steatohepatitis (NASH) given persistent cellular insult. The crux of the problem lies in fat accumulation in the liver, such as increase...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cureus
Glavni autori: Ghazanfar, Haider, Kandhi, Sameer D, Nawaz, Iqra, Javed, Nismat, Abraham, Minu C, Farag, Mohamed, Mahasamudram, Jaydeep, Patel, Vishwa B, Altaf, Faryal, Patel, Harish
Format: Artigo
Jezik:Inglês
Izdano: Cureus 2021
Teme:
Endocrinology/Diabetes/Metabolism
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8214471/
https://ncbi.nlm.nih.gov/pubmed/34164242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.15141
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items